Redhill Biopharma (STU:2RH) FCF Yield %: -216.26 (As of Jun. 30, 2026)


STU:2RH Redhill Biopharma Ltd STU:2RH
18 GF Score
Price €8.24
! 6 Warning Signs
View Full Analysis

What is Redhill Biopharma FCF Yield %?

Redhill Biopharma STU:2RH 18 FCF Yield % is -216.26 as of Jun. 30, 2026. GuruFocus rates STU:2RH with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 1,001 Drug Manufacturers companies, Redhill Biopharma ranks worse than 99.3% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Redhill Biopharma's Trailing 12-Month Free Cash Flow is €-8.31 Mil, and Market Cap is €42.75 Mil. Therefore, Redhill Biopharma's FCF Yield % for today is -216.26%.

The historical rank and industry rank for Redhill Biopharma's FCF Yield % or its related term are showing as below:

STU:2RH' s FCF Yield % Range Over the Past 10 Years
Min: -44291.53   Med: -47.39   Max: -11.01
Current: -216.26


During the past 13 years, the highest FCF Yield % of Redhill Biopharma was -11.01%. The lowest was -44291.53%. And the median was -47.39%.

STU:2RH's FCF Yield % is ranked worse than
99.3% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 0.65 vs STU:2RH: -216.26

Redhill Biopharma's FCF Margin % for the quarter that ended in Dec. 2025 was 122.26%.


Redhill Biopharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Redhill Biopharma FCF Yield % Related Terms


Redhill Biopharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Redhill Biopharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redhill Biopharma FCF Yield % Chart

Redhill Biopharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -54.63 -238.61 -131.50 -84.28 -19.66

Redhill Biopharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -132.48 -105.72 -57.39 -45.61 -18.88

STU:2RH vs SBFM, PRFX, CTTH: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redhill Biopharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redhill Biopharma FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redhill Biopharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Redhill Biopharma's FCF Yield % falls into.


STU:2RH
18GF Score
Redhill Biopharma Ltd STU:2RH
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redhill Biopharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Redhill Biopharma's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-8.246 / 41.94535
=-19.66%

Redhill Biopharma's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.96 * 2 / 41.94535
=-18.88%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -216.26 mean?
Redhill Biopharma (STU:2RH) has a FCF Yield % of -216.26 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Redhill Biopharma and its competitors. According to the industry distribution chart, Redhill Biopharma ranks #994 out of 1001 companies in the Drug Manufacturers industry, placing it in the top 99.3%.
Is Redhill Biopharma's FCF Yield % too high?
Redhill Biopharma's current FCF Yield % is -216.26. Based on the distribution chart, Redhill Biopharma ranks #994 out of 1001 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Redhill Biopharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Redhill Biopharma's FCF Yield % compare to SBFM and PRFX?
According to the Drug Manufacturers industry distribution chart, Redhill Biopharma ranks #994 out of 1001 companies for FCF Yield %. This places Redhill Biopharma in the lower half of its industry. The industry median FCF Yield % is 0.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.65, based on 1,001 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Redhill Biopharma and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redhill Biopharma's current FCF Yield % is -216.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redhill Biopharma stock overvalued right now?
Redhill Biopharma (STU:2RH) has a current FCF Yield % of -216.26. The current FCF Yield % is -216.26. Redhill Biopharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Redhill Biopharma (STU:2RH), the current FCF Yield % is -216.26 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redhill Biopharma Business Description

Other Exchanges RDHL:USA
Address 21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
18GF Score

Get the complete analysis for STU:2RH

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.24
Price